PROFOUND MEDICAL CORP (PROF) Stock Analyst Ratings
NASDAQ:PROF - Nasdaq - CA74319B5027 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to PROF. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.47. This target is 38.78% above the current price.
PROF was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PROF.
In the previous month the buy percentage consensus was at a similar level.
PROF was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-23 | Lake Street | Maintains | Buy -> Buy |
| 2024-07-16 | Stifel | Upgrade | Hold -> Buy |
| 2024-03-11 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2024-03-08 | Stifel | Maintains | Hold -> Hold |
| 2024-01-04 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2023-11-28 | Stifel | Initiate | Hold |
| 2023-08-04 | Raymond James | Downgrade | Strong Buy -> Outperform |
| 2023-05-11 | TD Cowen | Maintains | Outperform |
| 2023-05-11 | Alliance Global Partners | Maintains | Buy |
| 2023-03-21 | Jefferies | Downgrade | Buy -> Equal-Weight |
| 2022-11-04 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2022-03-07 | Cowen & Co. | Maintains | Outperform |
| 2022-02-22 | Raymond James | Downgrade | Strong Buy -> Outperform |
| 2021-07-28 | Raymond James Financial | Initiate | Strong Buy |
| 2021-05-13 | Raymond James Financial | Upgrade | Strong-Buy |
| 2021-03-10 | Raymond James Financial | Initiate | STRONG BUY |
| 2021-02-26 | Raymond James Financial | Reiterate | Strong Buy |